Research programme: eye disorder therapeutics - Imagen Biotech
Latest Information Update: 16 Jul 2016
At a glance
- Originator Imagen Biotech
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- No development reported Age-related macular degeneration; Eye disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Age-related-macular-degeneration in USA
- 16 Jul 2016 No recent reports of development identified for research development in Eye-disorders in USA
- 19 Oct 2011 Early research in Age-related macular degeneration in USA (unspecified route)